Aminolevulinic acid-based tumor detection and therapy: molecular mechanisms and strategies for enhancement

X Yang, P Palasuberniam, D Kraus, B Chen - International journal of …, 2015 - mdpi.com
Aminolevulinic acid (ALA) is the first metabolite in the heme biosynthesis pathway in
humans. In addition to the end product heme, this pathway also produces other porphyrin …

Melanoma resistance to photodynamic therapy: new insights

YY Huang, D Vecchio, P Avci, R Yin… - Biological …, 2013 - degruyter.com
Melanoma is the most dangerous form of skin cancer, with a steeply rising incidence and a
poor prognosis in its advanced stages. Melanoma is highly resistant to traditional …

5-Aminolevulinic acid as a theranostic agent for tumor fluorescence imaging and photodynamic therapy

R Howley, S Chandratre, B Chen - Bioengineering, 2023 - mdpi.com
5-Aminolevulinic acid (ALA) is a naturally occurring amino acid synthesized in all nucleated
mammalian cells. As a porphyrin precursor, ALA is metabolized in the heme biosynthetic …

ABCG2 transporter inhibitor restores the sensitivity of triple negative breast cancer cells to aminolevulinic acid-mediated photodynamic therapy

P Palasuberniam, X Yang, D Kraus, P Jones… - Scientific reports, 2015 - nature.com
Photosensitizer protoporphyrin IX (PpIX) fluorescence, intracellular localization and cell
response to photodynamic therapy (PDT) were analyzed in MCF10A normal breast …

Phthalocyanine derivatives possessing 2-(morpholin-4-yl) ethoxy groups as potential agents for photodynamic therapy

M Kucinska, P Skupin-Mrugalska… - Journal of Medicinal …, 2015 - ACS Publications
Three 2-(morpholin-4-yl) ethoxy substituted phthalocyanines were synthesized and
characterized. Phthalocyanine derivatives revealed moderate to high quantum yields of …

Multifunctional nanoplatforms as a novel effective approach in photodynamic therapy and chemotherapy, to overcome multidrug resistance in cancer

M Majerník, R Jendželovský, J Vargová… - Pharmaceutics, 2022 - mdpi.com
It is more than sixty years since the era of modern photodynamic therapy (PDT) for cancer
began. Enhanced selectivity for malignant cells with a reduced selectivity for non-malignant …

Targeting ABCG2 transporter to enhance 5-aminolevulinic acid for tumor visualization and photodynamic therapy

S Chandratre, J Olsen, R Howley, B Chen - Biochemical Pharmacology, 2023 - Elsevier
Aminolevulinic acid (ALA) has been approved by the US FDA for fluorescence-guided
resection of high-grade glioma and photodynamic therapy (PDT) of superficial skin …

Combinatorial approach of cannabidiol and active‐targeted‐mediated photodynamic therapy in malignant melanoma treatment

NW Nkune, H Abrahamse - Journal of biophotonics, 2024 - Wiley Online Library
Malignant melanoma (MM) continues to claim millions of lives around the world due to its
limited therapeutic alternatives. Photodynamic therapy (PDT) has gained popularity in …

The ABCG2 transporter is a key molecular determinant of the efficacy of sonodynamic therapy with Photofrin in glioma stem-like cells

ZY Xu, K Wang, XQ Li, S Chen, JM Deng, Y Cheng… - Ultrasonics, 2013 - Elsevier
We aimed to investigate the role of the ABCG2 transporter in the efficacy of sonodynamic
therapy (SDT) with Photofrin in the glioma stem-like cells (GSCs) isolated and cultured from …

[HTML][HTML] A combination of photodynamic therapy and chemotherapy displays a differential cytotoxic effect on human metastatic melanoma cells

FAN Biteghe, LM Davids - Journal of Photochemistry and Photobiology B …, 2017 - Elsevier
Background Cutaneous melanoma represents the most lethal form of skin cancer and
remains refractory to current therapies. Failure of treatment has been attributed to the over …